Loading...
Market
Story
Eli Lilly Sues Six Entities Over Fake Mounjaro and Zepbound on Thursday
Jun 20, 2024, 11:30 AM
US drugmaker Eli Lilly announced on Thursday morning that it is suing six additional entities, including medical spas and wellness centers, for selling products falsely claiming to contain tirzepatide, the active ingredient in its popular diabetes and weight loss medications Mounjaro and Zepbound. The company has issued an urgent warning in an open letter about the dangers of fake and compounded versions of these medications. Eli Lilly is broadening its efforts to crack down on counterfeit and off-brand versions of these drugs, which have seen increased demand for GLP-1-based drugs. The lawsuits and warnings are part of Eli Lilly's ongoing efforts to protect consumers and maintain the integrity of its products.
View original story
Similar markets
Yes • 50%
No • 50%
Less than 10,000 • 25%
10,000 to 20,000 • 25%
20,001 to 30,000 • 25%
More than 30,000 • 25%
Arrests made • 25%
No arrests but legal actions initiated • 25%
No legal actions taken • 25%
ZeroSevenGroup disbands • 25%
Yes • 50%
No • 50%
Celsius wins • 25%
Customer wins • 25%
Settlement reached • 25%
Case dismissed • 25%
No new lawsuits • 25%
New lawsuits under 100 • 25%
New lawsuits 100-500 • 25%
New lawsuits over 500 • 25%
Issue warning • 33%
Initiate legal action • 33%
No action taken • 33%